Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 8-9, 2009, Pages 1708-1718

  Mehrad, Borna ^a   Burdick, Marie D ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cell traffic; Chemokines; Lung; Signal transduction; Stem cells

Indexed keywords

BLEOMYCIN; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; LUNG FIBROSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLEOMYCIN; CELL HYPOXIA; CELL MOVEMENT; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MICE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASES; PULMONARY FIBROSIS; RECEPTORS, CXCR4; SIROLIMUS; UP-REGULATION;

ANIMALIA;

EID: 67349261972     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.02.020     Document Type: Article

References (59)

1. Abdollahi A., Li M., Ping G., Plathow C., Domhan S., Kiessling F., et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 201 (2005) 925-935
2. Abe R., Donnelly S.C., Peng T., Bucala R., and Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 (2001) 7556-7562
3. Andersson-Sjoland A., de Alba C.G., Nihlberg K., Becerril C., Ramirez R., Pardo A., et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol (2008)
4. Antoniades H.N., Bravo M.A., Avila R.E., Galanopoulos T., Neville-Golden J., Maxwell M., et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 86 (1990) 1055-1064
5. Aston C., Jagirdar J., Lee T.C., Hur T., Hintz R.L., and Rom W.N. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 151 (1995) 1597-1603
6. Brazelton T.R., and Morris R.E. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide. Curr Opin Immunol 8 (1996) 710-720
7. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 (2006) 1761-1767
8. Cashen A.F., Lazarus H.M., and Devine S.M. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?. Bone Marrow Transplant 39 (2007) 577-588
9. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (2004) 858-864
10. Christopher M.J., Liu F., Hilton M.J., Long F., and Link D.C. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood (2009)
11. Este J.A., and Telenti A. HIV entry inhibitors. Lancet 370 (2007) 81-88
12. Fasolo A., and Sessa C. mTOR inhibitors in the treatment of cancer. Expert Opin Investig Drugs 17 (2008) 1717-1734
13. Gomperts B.N., Belperio J.A., Rao P.N., Randell S.H., Fishbein M.C., Burdick M.D., et al. Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 176 (2006) 1916-1927
14. Harrison J.S., Rameshwar P., Chang V., and Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood 99 (2002) 394
15. Hashimoto N., Jin H., Liu T., Chensue S.W., and Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 (2004) 243-252
16. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (1999) 1283-1316
17. Ishida Y., Kimura A., Kondo T., Hayashi T., Ueno M., Takakura N., et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am J Pathol 170 (2007) 843-854
18. Ishii Y., Fujimoto S., and Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 174 (2006) 550-556
19. Kim K.K., Kugler M.C., Wolters P.J., Robillard L., Galvez M.G., Brumwell A.N., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103 (2006) 13180-13185
20. Kim K.K., Wei Y., Szekeres C., Kugler M.C., Wolters P.J., Hill M.L., et al. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119 (2009) 213-224
21. Klinghoffer R.A., Duckworth B., Valius M., Cantley L., and Kazlauskas A. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol Cell Biol 16 (1996) 5905-5914
22. Lawrence J.C., Lin T.A., McMahon L.P., and Choi K.M. Modulation of the protein kinase activity of mTOR. Curr Top Microbiol Immunol 279 (2004) 199-213
23. Martinet Y., Rom W.N., Grotendorst G.R., Martin G.R., and Crystal R.G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 317 (1987) 202-209
24. Mehrad B., Burdick M.D., Zisman D.A., Keane M.P., Belperio J.A., and Strieter R.M. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353 (2007) 104-108
25. Moeller A., Ask K., Warburton D., Gauldie J., and Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?. Int J Biochem Cell Biol 40 (2008) 362-382
26. Moeller A., Gilpin S.E., Ask K., Cox G., Cook D., Gauldie J., et al. Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009)
27. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166 (2005) 675-684
28. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., and Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 35 (2006) 175-181
29. Murdoch C. CXCR4: chemokine receptor extraordinaire. Immunol Rev 177 (2000) 175-184
30. Pan J., Mestas J., Burdick M.D., Phillips R.J., Thomas G.V., Reckamp K., et al. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 5 (2006) 56
31. Parmar K., Mauch P., Vergilio J.A., Sackstein R., and Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 104 (2007) 5431-5436
32. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Investig 114 (2004) 438-446
33. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., and Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167 (2003) 1676-1686
34. Phillips R.J., Mestas J., Gharaee-Kermani M., Burdick M.D., Sica A., Belperio J.A., et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280 (2005) 22473-22481
35. Pilewski J.M., Liu L., Henry A.C., Knauer A.V., and Feghali-Bostwick C.A. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 166 (2005) 399-407
36. Pilling D., Roife D., Wang M., Ronkainen S.D., Crawford J.R., Travis E.L., et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 179 (2007) 4035-4044
37. Quan T.E., Cowper S., Wu S.P., Bockenstedt L.K., and Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 36 (2004) 598-606
38. Rice A.B., Moomaw C.R., Morgan D.L., and Bonner J.C. Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 155 (1999) 213-221
39. Richard D.E., Berra E., and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 275 (2000) 26765-26771
40. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103 (2006) 14098-14103
41. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198 (2003) 1391-1402
42. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
43. Schwartz B.M., and Stats D. Oxygen saturation of sternal marrow blood in polycythemia vera. J Clin Invest 28 (1949) 736-740
44. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
45. Semenza G.L. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1 (2000) 159-162
46. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106 (2005) 3020-3027
47. Simler N.R., Howell D.C., Marshall R.P., Goldsack N.R., Hasleton P.S., Laurent G.J., et al. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J 19 (2002) 1124-1127
48. Skouby A.R. Haematologic adaptation in patients with chronic bronchitis and pulmonary insufficiency. Acta Med Scand 199 (1976) 185-190
49. Spangrude G.J. UNIT 4. 6 Assessment of lymphocyte development in radiation bone marrow chimeras Current Protocols in Immunology (2008), John Wiley & Sons, Hoboken, NJ p. 4.6.1-4.6.9
50. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425 (2003) 307-311
51. Sugiyama T., Kohara H., Noda M., and Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25 (2006) 977-988
52. Uh S.T., Inoue Y., King Jr. T.E., Chan E.D., Newman L.S., and Riches D.W. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158 (1998) 1626-1635
53. Vanhee D., Gosset P., Wallaert B., Voisin C., and Tonnel A.B. Mechanisms of fibrosis in coal workers' pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity. Am J Respir Crit Care Med 150 (1994) 1049-1055
54. Vannella K.M., McMillan T.R., Charbeneau R.P., Wilke C.A., Thomas P.E., Toews G.B., et al. Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J Immunol 179 (2007) 7883-7890
55. Wu Z., Yang L., Cai L., Zhang M., Cheng X., Yang X., et al. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res 8 (2007) 1
56. Yamada M., Kuwano K., Maeyama T., Hamada N., Yoshimi M., Nakanishi Y., et al. Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol 129 (2008) 453-462
57. Yasuoka H., Zhou Z., Pilewski J.M., Oury T.D., Choi A.M., and Feghali-Bostwick C.A. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am J Pathol 169 (2006) 1633-1642
58. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60 (2000) 1541-1545
59. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14 (2000) 391-396